The WHO has urgently approved Abbott Laboratories’ mpox diagnostic test amid rising global cases. The Alinity m MPXV assay detects the virus from skin lesion swabs, aiding rapid testing in outbreak regions. It marks a crucial step in controlling the spread, especially in underserved areas. Vulnerable groups, including children and those with weakened immune systems, face higher risks.World’s first mpox diagnostic test approved by WHO
The WHO has urgently approved Abbott Laboratories’ mpox diagnostic test amid rising global cases. The Alinity m MPXV assay detects the virus from skin lesion swabs, aiding rapid testing in outbreak regions. It marks a crucial step in controlling the spread, especially in underserved areas. Vulnerable groups, including children and those with weakened immune systems, face higher risks.